Optimum Imaging Strategies for Advanced Prostate Cancer
American Society of Clinical OncologyPublished: January 27, 2020
A digital version of this pocket guide is available for FREE at this link
- Introduction
- Treatment Recommendations
- Newly Diagnosed Clinically High-Risk/Very High-Risk Localized Prostate Cancer
- Conventional imaging negative
- Conventional imaging suspicious/equivocal
- Rising PSA after prostatectomy and negative conventional imaging (either initial PSA undetectable with subsequent rise or PSA never nadirs to undetectable)
- Rising PSA after radiotherapy and negative conventional imaging
- Metastatic prostate cancer at initial diagnosis or after initial treatment, hormone sensitive
- Non-metastatic CRPC (nmCRCP)
- Metastatic CRPC
- PSA progression
- Radiographic progression on conventional imaging
- Newly Diagnosed Clinically High-Risk/Very High-Risk Localized Prostate Cancer
- Algorithms
- Imaging Algorithm for High/Very High-Risk Disease at Initial Ptresentation (per National Comprehensive Cancer Network [NCCN])
- Imaging algorithm for patients with rising prostate-specific antigen (PSA) after local treatment
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.